Braxton Riley Schuldt

Braxton Riley Schuldt

Auto-generated profile, based on publicly available information

Braxton Riley Schuldt

Icahn School of Medicine at Mount Sinai

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Stroke
Verified
Journal Article
Closed access
MMMahmoud H. Mohammaden
Mahmoud H. Mohammaden
LVLorena Souza Viana
Lorena Souza Viana
HAHend Abdelhamid
Hend Abdelhamid
MOMarta Olive-Gadea
Marta Olive-Gadea
MRMarc Rodrigo-Gisbert
Marc Rodrigo-Gisbert
RNRaul G. Nogueira
Raul G. Nogueira
BACKGROUND: Endovascular treatment (EVT) is part of the usual care for proximal vessel occlusion strokes. However, the safety and effectiveness of EVT for distal medium vessel occlusions remain unclear. We sought to compare the clinical outcomes of EVT to medical management (MM) for isolated distal medium vessel occlusions. METHODS: This is a retrospective analysis of prospectively collected data from seven comprehensive stroke centers. Patients were included if they had isolated distal medium vessel occlusion strokes due to middle cerebral artery M3/M4, anterior cerebral artery A2/A3, or posterior cerebral artery P1/P2 segments. Patients treated with EVT or MM were compared with multivariable logistic regression and inverse probability of treatment weighting. The primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale (mRS) at 90 days. Secondary outcomes included 90-day good (mRS score, 0–2) and excellent (mRS score, 0–1) outcomes. Safety measures included symptomatic intracranial hemorrhage and 90-day mortality. RESULTS: A total of 321 patients were included in the analysis (EVT, 179; MM, 142; 40.8% treated with intravenous thrombolysis). In the inverse probability of treatment weighting model, there were no significant differences between EVT and MM in terms of the overall degree of disability (mRS ordinal shift; adjusted odds ratio [aOR], 1.25 [95% CI, 0.95–1.64]; P =0.110), rates of good (mRS score, 0–2; aOR, 1.32 [95% CI, 0.97–1.80]; P =0.075) and excellent (aOR, 1.32 [95% CI, 0.94–1.85]; P =0.098) outcomes, or mortality (aOR, 1.20 [95% CI, 0.78–1.85]; P =0.395) at 90 days. The multivariable regression model showed similar findings. Moreover, there was no difference between EVT and MM in rates of symptomatic intracranial hemorrhage in the multivariable regression model (aOR, 0.57 [95% CI, 0.21–1.58]; P =0.277), but the inverse probability of treatment weighting model showed a lower likelihood of symptomatic intracranial hemorrhage (aOR, 0.46 [95% CI, 0.24–0.85]; P =0.013) in the EVT group. CONCLUSIONS: This multicenter study failed to demonstrate any significant outcome differences among patients with isolated distal medium vessel occlusions treated with EVT versus MM. These findings reinforce clinical equipoise. Randomized clinical trials are ongoing and will provide more definite evidence.

13 August 2022 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
SMStavros Matsoukas
Stavros Matsoukas
JSJacopo Scaggiante
Jacopo Scaggiante
BSBraxton R. Schuldt
Braxton R. Schuldt
CSColton J. Smith
Colton J. Smith
SCSusmita Chennareddy
Susmita Chennareddy
CKChristopher Kellner
Christopher Kellner

23 May 2024 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
MMMahmoud H Mohammaden
Mahmoud H Mohammaden
MDMohamed F Doheim
Mohamed F Doheim
HAHend Abdelhamid
Hend Abdelhamid
SMStavros Matsoukas
Stavros Matsoukas
BSBraxton Riley Schuldt
Braxton Riley Schuldt
DHDiogo C Haussen
Diogo C Haussen
Background The optimal anesthesia modality during endovascular treatment (EVT) for distal medium vessel occlusion (DMVO) stroke is uncertain. We aimed to evaluate the association of the anesthesia modality with procedural and clinical outcomes following EVT for DMVO stroke. Methods This is a multicenter retrospective analysis of a prospectively collected database. Patients were included if they had DMVO involving the middle cerebral artery-M3/4, anterior cerebral artery-A2/3, or posterior cerebral artery-P1/P2-3, and underwent EVT. The cohort was divided into two groups, general anesthesia (GA) and non-general anesthesia (non-GA), and compared based on the intention-to-treat principle as primary analysis. We used propensity scores to balance the two groups. The primary outcome was the shift in the degree of disability as measured by the 90-day modified Rankin Scale (mRS). Secondary outcomes included successful reperfusion, as well as excellent (mRS 0–1) and good (mRS 0–2) clinical outcomes at 90 days. Safety measures included procedural complications, symptomatic intracerebral hemorrhage (sICH), and 90-day mortality. Results Among 366 DMVO thrombectomies, 61 matched pairs were eligible for analysis. Median age and National Institutes of Health Stroke Scale score as well as other baseline demographic and clinical characteristics were balanced between both groups. The GA group had no difference in the overall degree of disability (common OR 1.19, 95% CI 0.52 to 2.86, P=0.67) compared with the non-GA arm. Likewise, the GA group had comparable rates of successful reperfusion (OR 2.38, 95% CI 0.80 to 7.07, P=0.12), good/excellent clinical outcomes (OR 1.14, 95% CI 0.44 to 2.96, P=0.79/(OR 0.65, 95% CI 0.24 to 1.81, P=0.41), procedural complications (OR 1.00, 95% CI 0.19 to 5.16, P>0.99), sICH (OR 3.24, 95% CI 0.83 to 12.68, P=0.09), and 90-day mortality (OR 1.43, 95% CI 0.48 to 4.27, P=0.52) compared with the non-GA group. Conclusions In patients with DMVO, our study showed that GA and non-GA groups had similar procedural and clinical outcomes, as well as safety measures. Further larger controlled studies are warranted.

7 March 2023 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
MAMuhammad Ali
Muhammad Ali
CSColton Smith
Colton Smith
VVVikram Vasan
Vikram Vasan
MDMargaret Downes
Margaret Downes
BSBraxton R Schuldt
Braxton R Schuldt
CKChristopher Kellner
Christopher Kellner
Background Minimally invasive evacuation may help ameliorate outcomes after intracerebral hemorrhage (ICH). However, hospital length of stay (LOS) post-evacuation is often long and costly. Objective To examine factors associated with LOS in a large cohort of patients who underwent minimally invasive endoscopic evacuation. Methods Patients presenting to a large health system with spontaneous supratentorial ICH qualified for minimally invasive endoscopic evacuation if they met the following inclusion criteria: age ≥18, premorbid modified Rankin Scale (mRS) score ≤3, hematoma volume ≥15 mL, and presenting National Institutes of Health Stroke Scale (NIHSS) score ≥6. Demographic, clinical, radiographic, and operative characteristics were included in a multivariate logistic regression for hospital and ICU LOS dichotomized into short and prolonged stay at 14 and 7 days, respectively. Results Among 226 patients who underwent minimally invasive endoscopic evacuation, the median intensive care unit and hospital LOS were 8 (4–15) days and 16 (9–27) days, respectively. A greater extent of functional impairment on presentation (OR per NIHSS point 1.10 (95% CI 1.04 to 1.17), P=0.007), concurrent intraventricular hemorrhage (OR=2.46 (1.25 to 4.86), P=0.02), and deep origin (OR=per point 2.42 (1.21 to 4.83), P=0.01) were associated with prolonged hospital LOS. A longer delay from ictus to evacuation (OR per hour 1.02 (1.01 to 1.04), P=0.007) and longer procedure time (OR per hour 1.91 (1.26 to 2.89), P=0.002) were associated with prolonged ICU LOS. Prolonged hospital and ICU LOS were in turn longitudinally associated with a lower rate of discharge to acute rehabilitation (40% vs 70%, P<0.0001) and worse 6-month mRS outcomes (5 (4–6) vs 3 (2–4), P<0.0001). Conclusions We present factors associated with prolonged LOS, which in turn was associated with poor long-term outcomes. Factors associated with LOS may help to inform patient and clinician expectations of recovery, guide protocols for clinical trials, and select suitable populations for minimally invasive endoscopic evacuation.

4 May 2023 in World Neurosurgery
Verified
Journal Article
Closed access
CRChristina P Rossitto
Christina P Rossitto
IOIan C. Odland
Ian C. Odland
HOHolly Oemke
Holly Oemke
DCDanna Cruz
Danna Cruz
RKRoshini Kalagara
Roshini Kalagara
CKChristopher P. Kellner
Christopher P. Kellner

28 November 2022 in World Neurosurgery
Verified
Journal Article
Closed access
BSBraxton R. Schuldt
Braxton R. Schuldt
RKRoshini Kalagara
Roshini Kalagara
SCSusmita Chennareddy
Susmita Chennareddy
IOIan C. Odland
Ian C. Odland
MDMargaret H. Downes
Margaret H. Downes
CKChristopher P. Kellner
Christopher P. Kellner